Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amarin Declines as Investors Wait on Drug’s Exclusivity Decision
Amarin Declines as Investors Wait on Drug’s Exclusivity Decision
Amarin Declines as Investors Wait on Drug’s Exclusivity Decision
Submitted by
admin
on October 10, 2012 - 11:51am
Source:
Bloomberg
News Tags:
Amarin
exclusivity
Vascepa
hypertriglyceridemia
Headline:
Amarin Declines as Investors Wait on Drug’s Exclusivity Decision
Do Not Allow Advertisers to Use My Personal information
